Log in to save to my catalogue

Advancing targeted protein degradation for cancer therapy

Advancing targeted protein degradation for cancer therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8463487

Advancing targeted protein degradation for cancer therapy

About this item

Full title

Advancing targeted protein degradation for cancer therapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Cancer, 2021-10, Vol.21 (10), p.638-654

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The human proteome contains approximately 20,000 proteins, and it is estimated that more than 600 of them are functionally important for various types of cancers, including nearly 400 non-enzyme proteins that are challenging to target by traditional occupancy-driven pharmacology. Recent advances in the development of small-molecule degraders, inclu...

Alternative Titles

Full title

Advancing targeted protein degradation for cancer therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8463487

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8463487

Other Identifiers

ISSN

1474-175X,1474-1768

E-ISSN

1474-1768

DOI

10.1038/s41568-021-00365-x

How to access this item